
Intra-Cellular Therapies ITCI
Annual report 2024
added 02-21-2025
Intra-Cellular Therapies Total Inventories 2011-2026 | ITCI
Annual Total Inventories Intra-Cellular Therapies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.3 M | 11.6 M | 23.9 M | 7.95 M | 7.06 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.3 M | 7.06 M | 15.4 M |
Quarterly Total Inventories Intra-Cellular Therapies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.5 M | 20.1 M | 15.9 M | 11.6 M | 43 M | 41.9 M | 28.3 M | 23.9 M | 23.6 M | 25 M | 7.89 M | 7.95 M | 8.17 M | 7.77 M | 7.58 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 43 M | 7.06 M | 17.1 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.35 | -2.91 % | $ 359 M | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.61 | -3.59 % | $ 189 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 24.88 | -0.4 % | $ 3.04 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.55 | -4.14 % | $ 16 M | ||
|
Amicus Therapeutics
FOLD
|
229 M | $ 14.46 | 0.03 % | $ 4.46 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 315.4 | -4.52 % | $ 41.3 B | ||
|
Gilead Sciences
GILD
|
1.77 B | $ 138.37 | -1.26 % | $ 172 B |